Analyze Diet

Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence.

Abstract: To determine rate of decay of passively acquired antibodies in Standardbred foals on a farm with a high seroprevalence to equine arteritis virus (EAV) and to determine whether vertical or horizontal transmission of the virus was responsible for infection on the farm. Methods: Repeated-measures study. Methods: 46 Standardbred horses (15 brood mares and their foals, 5 stallions, and 11 young horses). Methods: Serum samples obtained from horses on the farm were evaluated by serum neutralization and western immunoblot analysis to detect EAV-specific antibodies. The half-life of passively acquired antibodies in foals was estimated by use of regression analysis. Results: Most (14/15) of the mares evaluated were seropositive to EAV. After suckling, their foals were also seropositive. Mean biological half-life for passively acquired antibodies in serum samples obtained from foals was 32 days (r2 = 0.61). The foal born to a seronegative dam and all 11 young horses from the farm were seronegative to EAV. At least 2 of 5 stallions on the farm were persistently infected carriers that were shedding virus in their semen. Immunoblot analysis of seropositive serum samples most consistently recognized the M protein of EAV. Conclusions: Analysis of these data indicated that a modified-live EAV vaccine can be administered to foals after they are 8 months old without risk of interference from maternal antibodies, regardless of serologic status of the foal's dam. Horizontal transmission of EAV via the respiratory tract apparently was uncommon on the farm, indicating that mares primarily were infected by venereal transmission of virus from carrier stallions.
Publication Date: 1998-09-23 PubMed ID: 9743724
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the decay rate of antibodies for the Equine Arterivirus in foals and its mode of transmission in a Standardbred horse farm with high infection rate. The results show that foals can be safely vaccinated after 8 months and highlights the central role of stallions in spreading the virus sexually.

Objective of the Study

  • The researchers aimed to understand the decay rate of passively acquired antibodies in Standardbred foals in a farm with a high prevalence of Equine Arteritis Virus (EAV).
  • They sought to ascertain whether the virus transmission on the farm was vertical (direct mother-to-foal transmission) or horizontal (from other infected horses).

Methodology

  • Their investigation was a repeated-measures study on 46 Standardbred horses comprising of 15 brood mares with their foals, 5 stallions, and 11 young horses.
  • They conducted serum neutralization and western immunoblot analyses on serum samples from the horses to detect EAV-specific antibodies.
  • The half-life of passively acquired antibodies in the foals was determined by regression analysis.

Results

  • Most of the mares (14 out of 15) werefound to be seropositive for EAV. Their foals, after being suckled by the mares, also tested positive.
  • The estimated average half-life of the passively acquired antibodies in the foals’ serum samples was 32 days.
  • The one foal born to a seronegative dam and all 11 young horses remained seronegative for EAV.
  • At least 2 of the 5 stallions were found to be long-term carriers that were shedding the EAV virus in their semen continually.
  • Among the seropositive serum samples presented for immunoblot examination, the most frequently acknowledged was the M protein of the EAV.

Conclusions

  • The researchers found a basis for administering a modified-live EAV vaccine to foals after they were eight months old without risk of interference from maternal antibodies, irrespective of the serologic condition of the foal’s dam.
  • The data suggests that horizontal transmission of EAV via the respiratory tract was uncommon within the farm. This implies that mares were primarily infected through sexual transmission of the virus from stallions who were carriers.

Cite This Article

APA
Hullinger PJ, Wilson WD, Rossitto PV, Patton JF, Thurmond MC, MacLachlan NJ. (1998). Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence. J Am Vet Med Assoc, 213(6), 839-842.

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 213
Issue: 6
Pages: 839-842

Researcher Affiliations

Hullinger, P J
  • Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616-8734, USA.
Wilson, W D
    Rossitto, P V
      Patton, J F
        Thurmond, M C
          MacLachlan, N J

            MeSH Terms

            • Animals
            • Antibodies, Viral / blood
            • Antibodies, Viral / immunology
            • Antibodies, Viral / metabolism
            • Antibody Specificity
            • Arterivirus Infections / immunology
            • Arterivirus Infections / transmission
            • Arterivirus Infections / veterinary
            • Carrier State / epidemiology
            • Carrier State / immunology
            • Carrier State / veterinary
            • Colostrum / immunology
            • Disease Transmission, Infectious
            • Equartevirus / immunology
            • Equartevirus / isolation & purification
            • Female
            • Half-Life
            • Horse Diseases / epidemiology
            • Horse Diseases / immunology
            • Horse Diseases / transmission
            • Horses
            • Immunity, Maternally-Acquired
            • Male
            • Prevalence
            • Semen / virology
            • Sexually Transmitted Diseases, Viral / immunology
            • Sexually Transmitted Diseases, Viral / transmission
            • Sexually Transmitted Diseases, Viral / veterinary

            Citations

            This article has been cited 3 times.
            1. Balasuriya UB, Go YY, MacLachlan NJ. Equine arteritis virus. Vet Microbiol 2013 Nov 29;167(1-2):93-122.
              doi: 10.1016/j.vetmic.2013.06.015pubmed: 23891306google scholar: lookup
            2. Wong DM, Alcott CJ, Clark SK, Jones DE, Fisher PG, Sponseller BA. Alloimmune neonatal neutropenia and neonatal isoerythrolysis in a Thoroughbred colt. J Vet Diagn Invest 2012 Jan;24(1):219-26.
              doi: 10.1177/1040638711416850pubmed: 22362958google scholar: lookup
            3. Hedges JF, Balasuriya UB, Timoney PJ, McCollum WH, MacLachlan NJ. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J Virol 1999 May;73(5):3672-81.